Ronald B. Moss

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Larry Smith, Mary K. Wloch, Ming Ye et al. · Vaccine · 2010 · 141 citations

Vaccination, Cross-protection, Vaccine Development +9

TNF-α and Chronic Fatigue Syndrome

Ronald B. Moss, Alexander Mercandetti, Aristo Vojdani · Journal of Clinical Immunology · 1999 · 137 citations

CD4+CD8dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens

Maria Suni, Smita Ghanekar, David W. Houck et al. · European Journal of Immunology · 2001 · 128 citations

Immunology, Cd4 T Cell Responses, Cd4+cd8dim T +16

Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein

Gallen Triana‐Baltzer, Larisa V. Gubareva, John M. Nicholls et al. · PLoS ONE · 2009 · 107 citations · Full text

DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center

Mirella Salvatore, Michael J. Satlin, Samantha E. Jacobs et al. · Biology of Blood and Marrow Transplantation · 2016 · 63 citations · Full text

Single Center, Parainfluenza Virus, Transplantation +12